1. 1529 Low risk of drug interactions when rolapitant is coadministered with CYP2D6 or BCRP substrates: Integrated safety results. (September 2015) Authors: Barbour, S.; Wang, X.; Poma, A.; Arora, S.; Aapro, M.; Herrstedt, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1590 Patient-related factors in determining the emetic risk potential for patients undergoing chemotherapy: An evaluation of predictive models for the development of a risk assessment tool. (September 2015) Authors: Aapro, M.; Dielenseger, P.; Dranitsaris, G.; Jordan, K.; Molassiotis, A.; Roeland, E.; Schwartzberg, L.; Warr, D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1596 Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia (CIN/FN) prophylaxis with biosimilar filgrastim and development of an outcomes risk calculator (MONITOR-GCSF study). (September 2015) Authors: Aapro, M.; Ludwig, H.; Bokemeyer, C.; Gascón, P.; Boccadoro, M.; Turner, M.; Denhaerynck, K.; MacDonald, K.; Abraham, I. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). (5th December 2016) Authors: Cardoso, F.; Costa, A.; Senkus, E.; Aapro, M.; André, F.; Barrios, C. H.; Bergh, J.; Bhattacharyya, G.; Biganzoli, L.; Cardoso, M. J.; Carey, L.; Corneliussen-James, D.; Curigliano, G.; Dieras, V.; El Saghir, N.; Eniu, A.; Fallowfield, L.; Fenech, D.; Francis, P.; Gelmon, K. Journal: Annals of oncology Issue: Volume 28:Number 1(2017) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). (February 2017) Authors: Cardoso, F.; Costa, A.; Senkus, E.; Aapro, M.; André, F.; Barrios, C.H.; Bergh, J.; Bhattacharyya, G.; Biganzoli, L.; Cardoso, M.J.; Carey, L.; Corneliussen-James, D.; Curigliano, G.; Dieras, V.; El Saghir, N.; Eniu, A.; Fallowfield, L.; Fenech, D.; Francis, P.; Gelmon, K. Journal: Breast Issue: Volume 31(2017) Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). (February 2017) Authors: Cardoso, F.; Costa, A.; Senkus, E.; Aapro, M.; André, F.; Barrios, C.H.; Bergh, J.; Bhattacharyya, G.; Biganzoli, L.; Cardoso, M.J.; Carey, L.; Corneliussen-James, D.; Curigliano, G.; Dieras, V.; El Saghir, N.; Eniu, A.; Fallowfield, L.; Fenech, D.; Francis, P.; Gelmon, K. Journal: Breast Issue: Volume 31(2017) Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bone health in the elderly cancer patient: A SIOG position paper. (December 2016) Authors: Body, J.J.; Terpos, E.; Tombal, B.; Hadji, P.; Arif, A.; Young, A.; Aapro, M.; Coleman, R. Journal: Cancer treatment reviews Issue: Volume 51(2016) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244–259]. (April 2017) Authors: Cardoso, F.; Costa, A.; Senkus, E.; Aapro, M.; André, F.; Barrios, C.H.; Bergh, J.; Bhattacharyya, G.; Biganzoli, L.; Cardoso, M.J.; Carey, L.; Corneliussen-James, D.; Curigliano, G.; Dieras, V.; El Saghir, N.; Eniu, A.; Fallowfield, L.; Fenech, D.; Francis, P.; Gelmon, K. Journal: Breast Issue: Volume 32(2017) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Integrated safety analysis of rolapitant with coadministered drugs from phase II/III trials: an assessment of CYP2D6 or BCRP inhibition by rolapitant. (23rd February 2017) Authors: Barbour, S.; Smit, T.; Wang, X.; Powers, D.; Arora, S.; Kansra, V.; Aapro, M.; Herrstedt, J. Journal: Annals of oncology Issue: Volume 28:Number 6(2017) Page Start: 1268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Management of breast cancer in elderly patients. (April 2021) Authors: Aapro, M. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗